期刊
NATURE BIOTECHNOLOGY
卷 27, 期 6, 页码 567-U110出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.1541
关键词
-
资金
- Leukemia & Lymphoma Society
- Elsa U. Pardee Foundation
- Howard Hughes Medical Institute
- California Institute for Regenerative Medicine
RNA interference (RNAi) induced by short interfering RNA (siRNA) allows for discovery research and large-scale screening(1-5); however, owing to their size and anionic charge, siRNAs do not readily enter cells(4,5). Current approaches do not deliver siRNAs into a high percentage of primary cells without cytotoxicity. Here we report an efficient siRNA delivery approach that uses a peptide transduction domain-double-stranded RNA-binding domain (PTD-DRBD) fusion protein. DRBDs bind to siRNAs with high avidity, masking the siRNA's negative charge and allowing PTD-mediated cellular uptake. PTD-DRBD-delivered siRNA induced rapid RNAi in a large percentage of various primary and transformed cells, including T cells, human umbilical vein endothelial cells and human embryonic stem cells. We observed no cytotoxicity, minimal off-target transcriptional changes and no induction of innate immune responses. Thus, PTD-DRBD-mediated siRNA delivery allows efficient gene silencing in difficult-to-transfect primary cell types.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据